Expression of TGF-β1, -β2 and -β3 in localized and systemic scleroderma

Journal of Dermatological Science

Volumn 21, Issue 1, 1999, Pages 13-22

  Querfeld, Christiane ^a   Eckes, Beate ^a   Huerkamp, Christina ^a   Krieg, Thomas ^a   Sollberg, Stephan ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Localized scleroderma; Systemic scleroderma; TGF ; Transforming growth factor

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; TRANSFORMING GROWTH FACTOR BETA3;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LYMPHOCYTIC INFILTRATION; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCLERODERMA; SKIN BIOPSY; SYSTEMIC SCLEROSIS; WOUND HEALING;

ADULT; AGED; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; MIDDLE AGED; PROTEIN ISOFORMS; RNA, MESSENGER; SCLERODERMA, SYSTEMIC; TRANSFORMING GROWTH FACTOR BETA; UP-REGULATION;

EID: 0032769817     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0923-1811(99)00008-0     Document Type: Article

References (28)

1. Fleischmajer R. The pathophysiology of scleroderma. Int J Dermatol. 16:1977;310-318.
2. Krieg T., Meurer M. Systemic scleroderma. Clinical and pathophysiologic aspects. J Am Acad Dermatol. 18:1988;457-481.
3. LeRoy E.C. A brief overview of the pathogenesis of scleroderma (systemic sclerosis). Ann Rheum Dis. 51:1992;286-288.
4. Kahaleh M.B. Vascular disease in scleroderma. Endothelial-T lymphocyte-fibroblast interactions. Rheum Dis Clin North Am. 16:1990;53-73.
5. Border W.A., Noble N.A. Transforming growth factor β in tissue fibrosis. New Engl J Med. 331:1994;1286-1292.
6. Roberts A.B., Sporn M.B., Assoian R.K. et al. Transforming growth factor type β: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci USA. 83:1986;4167-4171.
7. Connor T.B., Roberts A.B., Sporn M.B., Danielpour D., Dart L.L., Michels R.G., de Bustros S., Enger C., Kato H., Lansing M., Hayashi H., Glaser B.M. Correlation of fibrosis and transforming growth factor-β type 2 levels in the eye. J Exp Med. 163:1989;1661-1666.
8. Czaja M.J., Weiner F.R., Flanders K.C., Giambrone M.A., Wind R., Biempica L., Zern M.A. In vitro and in vivo association of transforming growth factor-β1 with hepatic fibrosis. J Cell Biol. 108:1989;2477-2482.
9. Border W.A., Ruoslahti E. Transforming growth factor-β1 induces extracellular matrix formation in glomerulonephritis. Cell Diff Dev. 32:1990;425-432.
10. Broekelmann T.J., Limper A.H., Colby T.V., McDonald J.A. Transforming growth factor β1 is present at sites of extracellular matrix gene expression in human pulmonary fibrosis. Proc Natl Acad Sci USA. 88:1991;6642-6646.
11. Coker R.K., Laurent G.J., Shahzeidi S., Lympany P.A., duBois R.M., Jeffery P.K., McAnulty R.J. Transforming growth factor-β1, -β2, and -β3 stimulate fibroblast procollagen production in vitro but are differentially expressed during bleomycin-induced lung fibrosis. Am J Pathol. 150:1997;981-991.
12. Kulozik M., Hogg A., Lankat-Buttgereit B., Krieg T. Co-localization of transforming growth factor β2 with α1(I) procollagen mRNA in tissue sections of patients with systemic sclerosis. J Clin Invest. 86:1990;917-922.
13. Sato M., Ishikawa O., Miyachi Y. An immunohistochemical study on transforming growth factor-β in the skin of systemic sclerosis patients with reference to the histopathologic stage. Eur J Dermatol. 6:1996;482-485.
14. Gruschwitz M., Müller P.U., Sepp N., Hofer E., Fontana A., Wick G. Transcription and expression of transforming growth factor type β in the skin of progressive systemic sclerosis: a mediator of fibrosis? J Invest Dermatol. 94:1990;197-203.
15. Peltonen J., Kähäri L., Jaakkola S., Kähäri V.M., Varga J., Uitto J., Jimenez S.A. Evaluation of transforming growth factor β and type I procollagen gene expression in fibrotic skin diseases by in situ hybridization. J Invest Dermatol. 94:1990;365-371.
16. Roberts A.B., Sporn M.B. The transforming growth factor-βs. Sporn M.B., Roberts A.B. Handbook of Experimental Pharmacology. Peptide Growth Factors. 95/1:1990;Springer, New York.
17. Lawrence D.A. Transforming growth factor-β: a general review. Eur Cytokine Netw. 7:1996;363-374.
18. Shah M., Foreman D.M., Ferguson M.W. Neutralizing antibody to TGF-β1,2 reduces cutaneous scarring in adult rodents. J Cell Sci. 107:1994;1137-1157.
19. Shah M., Foreman D.M., Ferguson M.W. Neutralization of TGF-β1 and TGF-β2 or exogenous addition of TGF-β3 to cutaneous rat wounds reduces scarring. J Cell Sci. 108:1995;985-1002.
20. Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostics and Therapeutic Criteria committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthr Rheum 1980;23:581-90.
21. Sambrook J., Fritsch E.F., Maniatis T. Molecular cloning. A Laboratory Manual. 2:1989;Cold Spring Harbor Laboratory Press, New York.
22. Scharffetter K., Lankat-Buttgereit B., Krieg T. Localization of collagen mRNA in normal and scleroderma skin by in situ hybridization. Eur J Clin Invest. 18:1988;9-17.
23. Igarashi A., Okochi H., Bradham D.M., Grotendorst G.R. Regulation of connective tissue growth factor gene expression in human skin fibroblasts and during wound repair. Mol Biol Cell. 4:1993;637-645.
24. Ruoslahti E., Yamaguchi Y., Hildebrand A., Border W.A. Extracellular matrix/growth factor interactions. Cold Spring Harb Symp Quant Biol. 57:1992;309-315.
25. Hildebrand A., Romaris M., Rasmussen L.M., Heinegard D., Twardzik D.R., Border W.A., Ruoslahti E. Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor β Biochem J. 302:1994;527-534.
26. Massagué J. Receptors for the TGF-β family. Cell. 69:1992;1067-1070.
27. Heldin C.H., Miyazono K., ten Dijke P. TGF-β signaling from cell membrane to nucleus through SMAD proteins. Nature. 390:1997;465-471.
28. Vuorio T., Kähäri V.M., Black C., Vuorio E. Expression of osteonectin, decorin, and transforming growth factor β1 genes in fibroblasts cultured from patients with systemic sclerosis and morphea. J Rheumatol. 18:1991;247-251.